(Sharecast News) - Syncona revealed on Monday that non-executive director John Roche had acquired 16,063 ordinary shares in the FTSE 250-listed healthcare investor.
Date:
22-Jun-26
Action:
Buy
Notifier:
John Roche
(Independent Non-Executive Director)
Price:
99.60
Amount:
16,063
Holding:
16,063
(Sharecast News) - Syncona reported broadly stable net asset value for the year ended 31 March on Thursday, as gains at Beacon Therapeutics offset weakness elsewhere in its life sciences portfolio, wh...
(Alliance News) - Syncona Ltd on Thursday reported a flat annual performance for net asset value, with upside from Beacon Therapeutics PLC offset by write-downs elsewhere.